Prism Medico & Pharmacy Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Revenue | 0.06 | 0.24 | 2.75 |
Operating Expense | 0.15 | 0.31 | 2.55 |
Net Profit | -0.09 | -0.07 | 0.19 |
Net Profit Margin | -150 | -29.17 | 6.91 |
Earning Per Share | TBA | -0.01 | 0.31 |
EBIDTA | -0.09 | -0.07 | 0.19 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2024 |
---|---|
Revenue | 0.06 |
Operating Expense | 0.15 |
Net Profit | -0.09 |
Net Profit Margin | -150.00 |
Earning Per Share | TBA |
EBIDTA | -0.09 |
Effective Tax Rate | TBA |
Invest in Prism Medico & Pharmacy Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 2.93 | 1.27 | 8.44 |
Operating Expenses Annual | 3.06 | 1.37 | 8.93 |
Operating Profit Annual | -0.02 | -0.10 | -0.49 |
Interest Annual | 0.01 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.01 | 0.01 |
Net Profit Annual | -0.02 | -0.08 | -0.37 |
Tax Annual | -0.01 | -0.03 | -0.13 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 2.93 |
Operating Expenses Annual | 3.06 |
Operating Profit Annual | -0.02 |
Interest Annual | 0.01 |
Depreciation | 0.01 |
Net Profit Annual | -0.02 |
Tax Annual | -0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 0.10 | 0.06 | 0.08 |
Cash Flow from Operations | -0.01 | 2.95 | -2.38 |
Cash Flow from Investing | TBA | -2.91 | 2.35 |
Cash Flow from Financing | -0.01 | TBA | TBA |
Cash Flow at the End | 0.08 | 0.10 | 0.06 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 0.10 |
Cash Flow from Operations | -0.01 |
Cash Flow from Investing | TBA |
Cash Flow from Financing | -0.01 |
Cash Flow at the End | 0.08 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | -0.34 | -7.87 | -5.81 |
PBIT Margin (%) | -0.68 | -8.66 | -5.92 |
PBT Margin (%) | 67.58 | -8.66 | -5.92 |
Net PROFIT Margin (%) | -0.68 | -6.30 | -4.38 |
Return On Networth / Equity (%) | -0.13 | -0.58 | -2.91 |
Return On Networth /Employed (%) | -0.13 | -0.79 | -3.93 |
Return On Assets (%) | -0.13 | -0.57 | -2.89 |
Total Debt / Equity (X) | TBA | TBA | TBA |
Asset Turnover Ratio (%) | 0.19 | 0.09 | 0.66 |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | -0.34 |
PBIT Margin (%) | -0.68 |
PBT Margin (%) | 67.58 |
Net PROFIT Margin (%) | -0.68 |
Return On Networth / Equity (%) | -0.13 |
Return On Networth /Employed (%) | -0.13 |
Return On Assets (%) | -0.13 |
Total Debt / Equity (X) | TBA |
Asset Turnover Ratio (%) | 0.19 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 0.03 | 0.03 | 0.05 |
Total Current Assets Annual | 14.99 | 15.15 | 12.34 |
Non Current Assets Annual | 0.25 | 0.25 | 0.23 |
Total Shareholders Funds Annual | 15.14 | 15.16 | 12.55 |
Total Assets Annual | 15.24 | 15.39 | 12.57 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 0.03 |
Total Current Assets Annual | 14.99 |
Non Current Assets Annual | 0.25 |
Total Shareholders Funds Annual | 15.14 |
Total Assets Annual | 15.24 |
EPS (INR)
Expected
0.00
Reported
-0.07
Surprise
0.00%
Sep 2019
EPS beaten by 0.00%
Jun 2019
EPS beaten by 0.00%
Mar 2019
EPS beaten by 0.00%